TITLE:
Role of Sulforaphane on Histone Deacetylase Activity in Solid Ehrlich Carcinoma
AUTHORS:
Mai M. El-Keey, Wafaa M. Ibrahim, Mohamad A. El-Ghonamy, Ehab Tousson, Tarek M. Mohamed
KEYWORDS:
Histone Deacetylase (HDAC), Sulforaphane (SFN), DNA Damage, Solid Ehrlich Carcinoma
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.8 No.3,
March
9,
2020
ABSTRACT: Histone acylation is one in every of the posttranslational modification that incorporates a role within the regulation of sequence expression. This study was aimed to ameliorate neoplasm cell model Solid Ehrlich malignant neoplastic disease with sulforaphane extracted from cabbage alone and together with immune suppressant drug (MTX) by study the activity of simple protein deacetylase accelerator (HDAC). In this study, sulforaphane was extracted from cabbage leaves and evaluated victimization GC-MS and ultraviolet illumination spectrophotometry. 60 white male rats were divided into six equal groups. Group I: management ordinarily. The remaining mice were subjected to Ehrlich neoplasm cells. Group II: Tumor-bearing group. Group III: immune suppressant drug “MTX” treated group. Group IV, V treated with SFN before and when Paul Ehrlich cells implantation group VI (Methotrexate and sulforaphane-treated group). This result showed that sulforaphane was extracted from cabbage (Brassica oleracea) in concentration of 833 μg/g leave. HDAC was attenuated when treatment with sulforaphane after treatment with methotrexate or sulforaphane alone. The desoxyribonucleic acid injury was attenuated in neoplasm tissue of tumor-bearing mice when treatment with immune suppressant drug and hyperbolic considerably in tumor tissue of tumor-bearing mice treated with sulforaphane before and after carcinogenesis and together with methotrexate treatment after carcinogenesis.